Home > Products > CD19 & CD47
> Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Minibody)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Minibody) (CAT#: MiniB-042)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD19 scFv fused to N-terminus of Knob-CH3 domain and the anti-CD47 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Minibody) (MiniB-042). Click the button below to contact us or submit your feedback about this product.